| Literature DB >> 31681785 |
Eman Ali1,2, Søren D Nielsen3, Salah Abd-El Aal4, Ahlam El-Leboudy5, Ebeed Saleh1, Gisèle LaPointe2.
Abstract
Peptides in the 3-kDa ultrafiltrate of fermented whey protein isolate (WPI) medium could be responsible for the antivirulence activity of Lactobacillus helveticus LH-2 and Lactobacillus acidophilus La-5 against Salmonella Typhimurium. Non-fermented and fermented media containing 5.6% WPI were fractionated at a 3 kDa cut-off and the filtrate was analyzed by mass spectrometry. The non-fermented WPI medium contained 109 milk derived peptides, which originated from β-casein (52), αs1-casein (22), αs2-casein (10), κ-casein (8), and β-lactoglobulin (17). Most of these peptides were not found in the fermented media, except for 14 peptides from β-casein and one peptide from αs2-casein. Database searches confirmed that 39 out of the 109 peptides had established physiological functions, including angiotensin-converting-enzyme (ACE) inhibitory, antioxidant, antimicrobial, or immunomodulating activity. A total of 75 peptides were found in the LH-2 cell free spent medium (CFSM): 54 from β-casein, 14 from k-casein, 4 from β-lactoglobulin and 3 from αs2-casein. From these peptides, 19 have previously been associated with several categories of bioactivity. For La-5 CFSM, a total of 15 peptides were sequenced: 8 from β-casein, 5 from αs1-casein, 2 from β-lactoglobulin. Only 5 of these have previously been reported as having bioactivity. Many of the peptides remaining in the fermented medium would contain low-affinity residues for oligopeptide binding proteins and higher resistance to peptidase hydrolysis. These properties of the sequenced peptides could explain their accumulation after fermentation despite the active proteolytic enzymes of LH-2 and La-5 strains. Down-regulated expression of hilA and ssrB genes in S. Typhimurium was observed in the presence of La-5 and LH-2 CFSM. Downregulation was not observed for the Salmonella oppA mutant strain exposed to the same CFSM used to treat the S. Typhimurium DT104 wild-type strain. This result suggests the importance of peptide transport by S. Typhimurium for down regulation of virulence genes in Salmonella.Entities:
Keywords: Salmonella; bioactive peptides; gene expression; probiotic; virulence; whey
Year: 2019 PMID: 31681785 PMCID: PMC6803757 DOI: 10.3389/fnut.2019.00152
Source DB: PubMed Journal: Front Nutr ISSN: 2296-861X
Oligonucleotides used in this study.
| Transcriptional regulator of SPI-1 | F: 5′-TGTCGGAAGATAAAGAGCAT-3′R: 5′-AAGGAAGTATCGCCAATGTA-3′ | ( | |
| Transcriptional regulator of SPI-2 | F: 5′-TGGTTTACACAGCATACCAA-3′R: 5′-GGTCAATGTAACGCTTGTTT-3′ | ( | |
| F: 5′-CAAGTCATCATGGCCCTTAC-3′R: 5′-CGGACTACGACGCACTTTAT-3′ | ( | ||
| Sigma factor, used as housekeeping gene | F: 5′-GTGAAATGGGCACTGTTGAACTG-3′R: 5′-TTCCAGCAGATAGGTAATGGCTTC-3′ | ( | |
| Guanylate kinase, used as housekeeping gene | F: 5′-TTGGCAGGGAGGCGTTT-3′R: 5′-GCGCGAAGTGCCGTAGTA AT-3′ | ( |
Figure 1Bioluminescence of S. Typhimurium hilA::lux (A) and ssrB::lux (B) measured after 3 h of incubation in LB broth alone (Untreated control), LB broth supplemented with 10% non-fermented WPI-sugar CFSM (Unfermented WPI) and LB broth supplemented with 10% L. helveticus LH-2 or L. acidophilus La-5 CFSM (Fermented WPI). Data are the means ± the standard deviations derived from triplicate assays and statistical analysis was carried out using ANOVA followed by Tukey's post hoc test. Different letters indicate significant differences (P-value of ≤ 0.05) within each subsection of the figure.
Figure 2Effect of L. helveticus LH-2 and L. acidophilus La-5 CFSM on virulence gene expression of S. Typhimurium DT104 and S. Typhimurium oppA mutant. Expression ratios of hilA and ssrB genes of S. Typhimurium were normalized to the expression of the geometric average of regulator genes 16S rRNA, rpoD, gmk to obtain the fold-change and compared with those of the non-fermented media.
Effect of L. helveticus LH-2 and L. acidophilus La-5 CFSM on virulence gene expression of S. Typhimurium DT104 and S. Typhimurium oppA mutant compared with the control CFSM.
| 90.25% | 6.46 ± 0.45 | 5.65 ± 0.33 | 6.61 ± 0.26 | 5.23 ± 0.09 | 5.32 ± 0.08 | 6.27 ± 0.17 | ||
| 7.00 ± 0.42 | 6.19 ± 0.28 | 6.22 ± 0.34 | 6.21 ± 0.42 | 6.08 ± 0.24 | 6.18 ± 1.23 | |||
| 93.73% | 22.58 ± 0.22 | 21.46 ± 0.20 | 22.07 ± 0.09 | 19.37 ± 0.21 | 20.75 ± 0.18 | 23.73 ± 0.47 | ||
| 22.21 ± 0.18 | 21.22 ± 0.18 | 21.11 ± 0.27 | 21.23 ± 0.21 | 21.45 ± 0.24 | 22.86 ± 2.78 | |||
| 101.69% | 29.19 ± 0.82 | 26.95 ± 0.46 | 28.61 ± 0.33 | 25.59 ± 0.58 | 27.96 ± 0.08 | 32.28 ± 0.76 | ||
| 31.12 ± 0.76 | 29.16 ± 0.54 | 29.27 ± 2.23 | 29.63 ± 0.44 | 29.48 ± 0.64 | 32.38 ± 2.76 | |||
| 96.37% | 23.69 ± 0.36 | 25.31 ± 0.32 | 27.29 ± 0.14 | 20.74 ± 0.31 | 25.41 ± 0.17 | 25.94 ± 0.44 | ||
| 27.07 ± 0.25 | 27.08 ± 0.27 | 27.68 ± 0.48 | 27.74 ± 0.51 | 29.41 ± 0.31 | 30.96 ± 1.64 | |||
| 97.63% | 26.29 ± 0.34 | 26.21 ± 0.22 | 27.41 ± 0.33 | 22.35 ± 0.06 | 26.67 ± 0.42 | 27.78 ± 0.46 | ||
| 26.14 ± 0.62 | 27.02 ± 0.26 | 27.05 ± 0.53 | 26.64 ± 0.79 | 27.03 ± 0.44 | 28.55 ± 2.41 | |||
Comparative genome analysis of the proteolytic system of L. helveticus LH-2 with L. helveticus CNRZ 32 (abbreviation LAC LHE, accession number CP002081) at the nucleotide level using NCBI microbial genome database and Blast alignment tools.
| 0 | |
| 0 | |
| 4,913/4,914 (99%) | |
| 4,974/4,977 (99%) | |
| 0 | |
| 903/903 (100%) | |
| oligopeptide ABC transport protein ATP-binding component | 314/314 (100%) |
| oligopeptide ABC transport protein ATP-binding component | 351/352 (99%) |
| oligopeptide ABC transport protein ATP-binding component | 328/328 (100%) |
| oligopeptide ABC transport protein ATP-binding component | 342/344 (99%) |
| oligopeptide ABC transport protein periplasmic component | 496/510 (97%) |
| oligopeptide ABC transport protein periplasmic component | 538/540 (99%) |
| oligopeptide ABC transport protein ATP-binding component | 309/309 (100%) |
| oligopeptide ABC transport protein permease component | 269/269 (100%) 285/286 (99%) |
| Oligoendopeptidase | 2,363/2,370 (99%) |
| Oligoendopeptidase | 2,690/2,691 (99%) |
| Oligoendopeptidase | 1,939/1,947 (99%) |
| sialoglycoprotein endopeptidase | 1,050/1,050 (100%) |
| General aminopeptidases | 1,314/1,314 (100%) |
| General aminopeptidases | 1,349/1,350 (99%) |
| General aminopeptidases | 3,754/3,787 (99%) |
| X-prolyl diaminopeptidase | 3,204/3,204 (100%) |
| Proline iminopeptidases | 885/885 (100%) |
| Proline iminopeptidases | 1,259/1,260 (99%) |
| Prolidase | 2,177/2,181 (99%) |
| Prolidase | 1,110/1,110 (100%) |
| Dipeptidase | 2,244/2,253 (99%) |
| Dipeptidase | 1,422/1,422 (100%) |
| Dipeptidase | 1,424/1,428 (99%) |
| Dipeptidase | 2,402/2,404 (99%) |
| Tripeptidase | 1,242/1,242 (100%) |
| Tripeptidase | 1,287/1,287 (100%) |
| Glutamyl aminopeptidase | 1,083/1,083 (100%) |
| Methionine aminopeptidase | 828/828 (100%) |
| Pyrrolidone carboxyl peptidase | 603/603 (100%) |
| SprT-like metallopeptidase | 470/471 (99%) |
| M16 family metallopeptidase hyp | 1,257/1,257 (100%) |
| Membrane alanine aminopeptidase | 1,515/1,515 (100%) |
Comparative genome analysis of the proteolytic system of L. acidophilus La-5 with L. acidophilus NCFM (abbreviation LAC, accession code CP000033) at the nucleotide level using NCBI microbial genome database and Blast alignment tools.
| 1,626/1,627 (99%) | |
| 300/300 (100%) | |
| Oligopeptide binding protein | 1,626/1,626 (100%) |
| Oligopeptide ABC transporter, binding protein | 542/542 (100%) |
| Oligopeptide ABC transporter, permease protein | 309/309 (100%) |
| Oligopeptide ABC transporter, permease protein | 343/343 (100%) |
| Oligopeptide ABC transporter, ATP binding protein | 352/352 (100%) |
| Oligopeptide ABC transporter, ATP binding protein | 313/314 (99%) |
| Oligopeptide ABC transporter, substrate binding protein | 527/527 (100%) |
| Oligopeptide ABC transporter, substrate binding protein | 584/585 (99%) |
| Oligopeptide ABC transporter, substrate binding protein | 589/589 (100%) |
| Oligopeptide ABC transporter, permease protein | 309/309 (100%) |
| Oligopeptide ABC transporter, permease protein | 105/319 (33%) |
| Oligopeptide ABC transporter, ATP binding protein | 328/328 (100%) |
| Oligopeptide ABC transporter, ATP binding protein | 342/343 (99%) |
| Oligopeptide ABC transporter, substrate binding protein | 581/581 (100%) |
| Oligopeptide ABC transporter, substrate binding protein | 542/542 (100%) |
| Dipeptidase ( | 466/466 (100%) |
| Prolyl aminopeptidase ( | 293/293 (100%) |
| Metallopeptidase | 649/650 (99%) |
| Pyrrolidone carboxyl peptidase ( | 200/200 (100%) |
| Dipeptidase | 437/437 (100%) |
| Dipeptidase | 438/438 (100%) |
| Prepilin peptidase ( | 228/229 (99%) |
| Aminopeptidase C | 449/449 (100%) |
| Endopeptidase ( | 348/349 (99%) |
| Xaa-pro dipeptidase ( | 1,117/1,117 (100%) |
| 274/275 (99%) | |
| 437/437 (100%) | |
| 467/467 (100%) | |
| Signal peptidase ( | 256/257 (99%) |
| 427/427 (100%) | |
| 649/650 (99%) | |
| 1,124/1,124 (100%) | |
| 596/596 (100%) | |
| 793/793 (100%) | |
| 427/427 (100%) | |
| 1,312/1,312 (100%) | |
| Prolyl aminopeptidase ( | 928/928 (100%) |
| 598/598 (100%) | |
| 844/844 (100%) | |
| Signal peptidase ( | 210/210 (100%) |
| 299/299 (100%) | |
Specific proteinase and aminopeptidase activities of intact cells and intracellular enzymatic extract of L. helveticus LH-2 and L. acidophilus La-5 after growth anaerobically in WPI—sugar based media at 37°C for 24 h.
| 35 | 1.66 ± 0.04 | 0.05± | 19.74 ± 0.27 | 5.19 ± 0.55 |
| 40 | 2.12 ± 0.11 | 0.25 ± 0.01 | 22.06 ± 0.60 | 4.08 ± 0.74 |
| 45 | 3.60± | 0.14 ± 0.01 | 7.82 ± 0.91 | 4.43 ± 0.37 |
| 50 | 3.44 ± 0.03 | 0.21 ± 0.01 | 3.41 ± 0.23 | 2.15 ± 0.72 |
| 55 | 3.01 ± 0.03 | 0.06 ± 0.01 | 14.78 ± 1.32 | 2.75 ± 0.36 |
Values are the means and SD of independent triplicates. non- detectable (nd) = SD <0·01. Specific enzyme activity is expressed as nmoles ρNa released /mg protein/min.
Figure 3The Venn diagram shows the number and distribution of milk peptides in non-fermented WPI and WPI fermented with L. helveticus LH-2 or L. acidophilus La-5.
Figure 4Heat maps of bovine β-, αs1-, αs2-, κ-casein, and β-lactoglobulin. Each amino acid was colored according to the number of peptides in which this amino acid was found.
Figure 5Bovine β-casein derived peptides identified in non-fermented WPI and WPI fermented with L. helveticus LH-2 and L. acidophilus La-5. Negative charged amino acids (Aspartate D, glutamate E) are in italics, Glycine G, Proline P, and Glutamine Q at position 4, 5, or 6 are marked with bold. P at second position is marked with bold and underline. VPP and IPP are inverse colors (white characters on black background). Phosphorylation sites are marked with a black dot above the serine. Cleavage sites of endogenous milk proteases are adapted from Baum et al. (34) and marked with colored vertical arrows.
Figure 8Bovine κ-casein derived peptides identified in non-fermented control WPI and WPI fermented with L. helveticus LH-2 or L. acidophilus La-5. Negative charged amino acids (Aspartate D, glutamate E) are in italics, Glycine G, Proline P, and Glutamine Q at position 4, 5, or 6 are marked with bold. P at second position is marked with bold and underline. VPP and IPP are inverse colors (white characters on black background). Phosphorylation sites are marked with a black dot above the serine. Cleavage sites of endogenous milk proteases are adapted from Hurley et al. (35) and are marked with colored vertical arrows.
Figure 9Bovine β-lactoglobulin derived peptides identified in non-fermented control WPI and WPI fermented with L. helveticus LH-2 or L. acidophilus La-5. Negative charged amino acids (Aspartate D, glutamate E) are in italics, Glycine G, Proline P, and Glutamine Q at position 4, 5, or 6 are marked with bold. P at second position is marked with bold and underline. VPP and IPP are inverse colors (white characters on black background). Phosphorylation sites are marked with a black dot above the serine.
Bioactive peptides identified in Control WPI and WPI fermented with L. helveticus LH-2 and L. acidophilus La-5 strains by searching the Milk Bioactive Peptide Database with the reported function of the identified peptides.
| Bovine β-CN | RELEELNVPGEIVE | ACE-inhibitory | X | ( | ||
| ELQDKIHPF | ACE-inhibitory | X | ( | |||
| SLVYPFPGPIPN | ACE-inhibitory | X | ( | |||
| LVYPFPGPIPN | ACE-inhibitory | X | ( | |||
| VYPFPGPI | Prolyl endopeptidase-inhibitory | X | ( | |||
| VYPFPGPIPN | Antioxidant, ACE-inhibitory | X | ( | |||
| SLPQNIPPLTQTPV | ACE-inhibitory | X | ( | |||
| SLPQNIPPLTQTPVVVPPFLQPEVM | ACE-inhibitory | X | ( | |||
| LPQNIPPL | Antidiabetic | X | ( | |||
| TQTPVVVPPFLQPE | Antioxidant | X | ( | |||
| GVSKVKEAMAPK | Antioxidant | X | X | X | ( | |
| VKEAMAPK | Antibacterial,!!break Antioxidant, ACE-inhibitory | X | ( | |||
| HKEMPFPKYPVEPF | Opioid | X | ( | |||
| EMPFPKYPVEPF | ACE-inhibitory | X | ( | |||
| NLHLPLPLLQ | ACE-inhibitory | X | X | ( | ||
| MHQPHQPLPPT | Antirotaviral Activity | X | ( | |||
| HQPHQPLPPT | Immunomodulatory | X | ( | |||
| SLSQSKVLPVPQ | Antioxidant | X | ( | |||
| SQSKVLPVPQ | ACE-inhibitory | X | X | ( | ||
| RDMPIQAF | ACE-inhibitory | X | ( | |||
| LLYQEPVLGPVRGPFPIIV | ACE-inhibitory, Immunomodulatory, Antithrombin, Antimicrobial | X | ( | |||
| LYQEPVLGPVRGPFPIIV | Mitogen | X | ( | |||
| YQEPVLGPVRGPFP | ACE-inhibitory | X | ( | |||
| YQEPVLGPVRGPFPI | Antimicrobial | X | ( | |||
| YQEPVLGPVRGPFPIIV | Immunomodulatory, Antimicrobial | X | ( | |||
| QEPVLGPVRGPFPIIV | ACE-inhibitory, Antioxidant | X | ( | |||
| EPVLGPVRGPFPIIV | ACE-inhibitory | X | ( | |||
| DKIHPFA | ACE-inhibitory | X | ( | |||
| YPFPGPIHNSLPQ | Opioid | X | ( | |||
| LPQNIPPLTQTPV | Antidiabetic, ACE-inhibitory | X | ( | |||
| IPPLTQTPVVVPP | ACE-inhibitory | X | ( | |||
| TPVVVPPFL | ACE-inhibitory | X | ( | |||
| PVVVPPFLQPE | Antimicrobial | X | ( | |||
| DVENLHLPLPL | ACE-inhibitory | X | X | ( | ||
| LHLPLPLLQS | ACE-inhibitory | X | ( | |||
| HLPLPLLQ | Enteric nervous system development | X | ( | |||
| SLSQSKVLPVPQK | Antioxidant | X | ( | |||
| LPVPQKAVPYPQ | Antioxidant | X | ( | |||
| Bovine αs1-CN | EVLNENLLRF | ACE-inhibitory | X | ( | ||
| FVAPFPEVFGK | ACE-inhibitory | X | ( | |||
| VAPFPEVFGKE | ACE-inhibitory | X | ( | |||
| VPQLEIVPNSAEER | Mineral carriers, anti-caries activity | X | ( | |||
| Bovine αs2-CN | LYQGPIVLNPWDQVK | ACE-inhibitory | X | ( | ||
| NAVPITPT | ACE-inhibitory | X | ( | |||
| NAVPITPTL | Antioxidative | X | ( | |||
| Bovine κ-CN | YYQQKPVA | Antibacterial | X | ( | ||
| MAIPPKKNQDKTEIPTIN | Antithrombotic, Antibacterial | X | ( | |||
| TVQVTSTAV | Antibacterial | X | ( | |||
| EIPTINT | Antibacterial | X | ( | |||
| EVIESPPEINTVQVT | ACE-inhibitory, zinc-chelation | X | ( | |||
| Bovine β-LG | IIAEKTKIPA | ACE-inhibitory | X | ( | ||
| LIVTQTMK | Cytotoxic | X | ( | |||
| IDALNENK | Antibacterial | X | ( | |||
| VLVLDTDYK | Antibacterial, DPP-IV inhibitory | X | ( | |||
| AASDISLLDAQSAPLR | Antibacterial | X | ( | |||
| GLDIQKVAGT | ACE-inhibitory, Antibacterial | X | X | ( | ||
| GLDIQKVAGTW | ACE-inhibitory | X | ( |